The conjugation of DTX to the polyanionic inhibitory peptide EGGEGGEGG, the MMP-2/9-sensitive cleavable peptide (PVGLIG) and the cell-penetrating domain R9 was associated with enhanced cancer cell-specific uptake of DTX in MMP-2/9-overexpressing tumor tissues. Here, MMP2 is linked to cancer.